1. Home
  2. GPMT vs ABOS Comparison

GPMT vs ABOS Comparison

Compare GPMT & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • ABOS
  • Stock Information
  • Founded
  • GPMT 2015
  • ABOS 1996
  • Country
  • GPMT United States
  • ABOS United States
  • Employees
  • GPMT N/A
  • ABOS N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • ABOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GPMT Real Estate
  • ABOS Health Care
  • Exchange
  • GPMT Nasdaq
  • ABOS Nasdaq
  • Market Cap
  • GPMT 122.0M
  • ABOS 103.6M
  • IPO Year
  • GPMT 2017
  • ABOS 2021
  • Fundamental
  • Price
  • GPMT $2.75
  • ABOS $1.88
  • Analyst Decision
  • GPMT Buy
  • ABOS Strong Buy
  • Analyst Count
  • GPMT 3
  • ABOS 3
  • Target Price
  • GPMT $3.13
  • ABOS $8.00
  • AVG Volume (30 Days)
  • GPMT 204.3K
  • ABOS 410.3K
  • Earning Date
  • GPMT 11-05-2025
  • ABOS 11-11-2025
  • Dividend Yield
  • GPMT 7.29%
  • ABOS N/A
  • EPS Growth
  • GPMT N/A
  • ABOS N/A
  • EPS
  • GPMT N/A
  • ABOS N/A
  • Revenue
  • GPMT N/A
  • ABOS N/A
  • Revenue This Year
  • GPMT N/A
  • ABOS N/A
  • Revenue Next Year
  • GPMT $26.51
  • ABOS N/A
  • P/E Ratio
  • GPMT N/A
  • ABOS N/A
  • Revenue Growth
  • GPMT N/A
  • ABOS N/A
  • 52 Week Low
  • GPMT $1.61
  • ABOS $0.86
  • 52 Week High
  • GPMT $3.66
  • ABOS $3.36
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 37.65
  • ABOS 67.95
  • Support Level
  • GPMT $2.93
  • ABOS $1.67
  • Resistance Level
  • GPMT $3.03
  • ABOS $1.86
  • Average True Range (ATR)
  • GPMT 0.08
  • ABOS 0.16
  • MACD
  • GPMT -0.04
  • ABOS 0.06
  • Stochastic Oscillator
  • GPMT 0.03
  • ABOS 73.86

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: